(Q35172086)

6 August 2017

1 reference

title

Autoantibody-mediated atherosclerosis (English)

1 reference

6 August 2017

1 reference

1 reference

4

Yehuda Shoenfeld

1 reference

6 August 2017

1

Eiji Matsuura

1 reference

6 August 2017

3

Takao Koike

1 reference

6 August 2017

2

Kazuko Kobayashi

1 reference

6 August 2017

1 December 2002

1 reference

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

348-353

1 reference

6 August 2017

6

1 reference

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

The concept and classification of antiphospholipid/cofactor syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Cholesteryl hydroperoxyoctadecadienoate from oxidized low density lipoprotein inactivates platelet-derived growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Oxysterols and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Identification of cholesterol-bound aldehydes in copper-oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Immune complexes of LDL induce atherogenic responses in human monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900084-8

7 January 2021

10.1016/S1568-9972(02)00084-8

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12848990